Monitor for any future conversion to a 13D filing, which would signal a shift to activist intent. The 8.3% stake is notable but below the typical threshold for immediate activist pressure; the passive designation suggests a long-term investment thesis tied to Retension's pipeline.
Price Chart
Executive Summary
PVG Asset Management Corp disclosed a passive 8.3% stake in Retension Pharmaceuticals via a Schedule 13G filed October 16, 2026, representing 1,002,050 shares of common stock. The filing indicates no intent to influence or change control of the company, consistent with a routine passive investment by a registered investment adviser.
Key Financial Metrics
Key Facts
- PVG Asset Management Corp reported beneficial ownership of 1,002,050 shares of Retension Pharmaceuticals common stock.
- The stake represents 8.3% of outstanding shares as of October 9, 2026.
- Filed under Rule 13d-1(b), confirming passive intent with no control-related purpose.
- This is a new filing; no prior SC 13G from PVG Asset Management for this issuer was found in the provided context.
Financial Impact
8.3% passive stake valued at approximately $1,002,050 based on the filing's stated dollar amount (likely cost basis or market value at acquisition).
Risk Factors
- PVG Asset Management could later convert to a 13D and seek changes, though no such intent is indicated.
- A large passive holder may reduce liquidity if it decides to exit the position.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000820434-26-000008 |
| Document: 0000820434-26-000008-index.html | 0000820434-26-000008 |
| Document: 0000820434-26-000008.txt | 0000820434-26-000008 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $15.25 | awaiting T+5 | — | $13.52 (−11.34%) |
Oct 16, 2026 10d ago | SC 13G | $16.33 $14.65 | ▼ −10.29% | ▼ −10.14% | $13.52 (−17.21%) |
Oct 16, 2026 11d ago | SC 13G | $14.07 $15.25 | ▲ +8.39% | ▲ +8.82% | $13.52 (−3.91%) |
Oct 15, 2026 12d ago | SC 13G | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $13.52 (+10.73%) |
Oct 14, 2026 13d ago | SC 13D | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $13.52 (+10.73%) |
Oct 13, 2026 13d ago | Insider Cluster | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $13.52 (+16.15%) |
Oct 13, 2026 13d ago | 3 | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $13.52 (+16.15%) |
Oct 9, 2026 17d ago | 424B4 | $11.32 $16.33 | ▲ +44.26% | ▲ +45.75% | $13.52 (+19.43%) |
Oct 9, 2026 18d ago | EFFECT | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $13.52 (+28.40%) |
Oct 8, 2026 18d ago | 3 | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $13.52 (+28.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers